Back to catalogue
№ 170 22 filings · 2021-09-28 → 2026-07-31

FERRO-ALLOY RESOURCES LIMITED

FAR
Basic Resources Share price 3.70p Market cap £28m Overall fit 90 /1000

Poor fit for the investor's strategy: no AI-receiver angle (vanadium for steel and stationary batteries), fragile balance sheet with imminent bond wall and material going-concern uncertainty, pre-production so operating leverage is theoretical, and any upside requires heroic execution plus non-dilutive financing.

Fair value range 2p–6p Mid case · £24m
Absolute upside -15.9% vs current market cap
Conviction 2/5 confidence in fair call
Supports the call
  • Detailed feasibility study with independent consultants
  • Clear bond maturity schedule and cash position disclosed
  • Multiple valuation anchors (FS NPV, current mcap, bond stress)
Limits the call
  • Binary near-term solvency outcome dominates value
  • Dilution price for US$312m Phase 1 financing is unknowable
Methodology

Risk-weighted NAV: probability-blended feasibility NPV net of dilution vs distress scenario

In one line · bull case

World-class vanadium deposit with genuinely differentiated economics that could be transformational for equity holders — but only if the company can refinance imminent bond maturities and secure US$312m of Phase 1 funding without catastrophic dilution.

In one line · biggest risk

Bond maturities of US$13m falling due in August-October 2026 against US$2.16m cash create a real near-term solvency risk that could wipe out equity holders before the Phase 1 opportunity is ever tested.

Drivers
AI beneficiary 12 /100
Vanadium for steel alloys and VRFB stationary batteries; no direct AI-buildout exposure and no material data-centre linkage disclosed.
Operating leverage 55 /100
Theoretical high leverage once Phase 1 is built (cash cost US$0.36/lb after by-products) but pre-production so not yet a live driver.
Earnings vs expectations 25 /100
Feasibility study delayed multiple times 2023-2025 and production repeatedly constrained by supply and geopolitical disruption.
Growth momentum 30 /100
FY25 revenue US$4.5m fell versus US$4.7m in FY24; existing operation is intentionally kept sub-scale as R&D centre pending Phase 1.
Moat 40 /100
Genuinely differentiated black-shale deposit with structurally lower processing costs, but no scale, brand or switching-cost moat as a small pre-production developer.
Earnings quality 25 /100
Loss-making with heavy capitalisation of feasibility-study costs (US$10.5m E&E asset); revenue is subject to provisional-pricing fair-value adjustments.
Management quality 45 /100
Strong board additions (Sir Mick Davis, incoming CEO Peter Secker) offset by long history of delays, chronic dilution and directors accepting scrip in lieu of cash.
Cyclicality 85 /100
Deeply cyclical vanadium and molybdenum pricing; commentary in filings shows swings from US$5/lb to US$12/lb V2O5 across the period.
Leverage 78 /100
US$18m of bonds outstanding vs US$2.16m cash at March 2026 and US$13m of maturities within 60 days; material uncertainty over going concern.
Value-trap signals · 5
  • Auditor material uncertainty re going concern in FY24 and FY25 accounts
  • US$13m of bond maturities in August-October 2026 versus US$2.16m cash at March 2026
  • Repeated multi-quarter feasibility-study delays across four years
  • Persistent dilutive equity issuance at falling prices, including scrip in lieu of director/supplier cash
  • Share price down 44% over 12 months and -17.6% single-day at the data snapshot

FERRO-ALLOY RESOURCES LIMITED (FAR) — Research Note

Executive summary

Ferro-Alloy Resources is a pre-production developer of the Balasausqandiq vanadium deposit in southern Kazakhstan, with a small existing R&D/processing plant that generated US$4.5m revenue in FY25 while accumulating a US$8.4m loss. The trajectory over the period covered is one of a low-margin research operation carrying the corporate overhead while the company works towards a US$312m Phase 1 mine construction that would produce 8,500 tonnes p.a. of V2O5. The single most important point for valuation today is the imminent Kazakh bond maturity wall (US$13m due August 2026) against just US$2.16m of cash — a solvency issue that overwhelms the theoretical Phase 1 NPV of US$932m 2026-07-31 strategic update; 2026-04-30 final results.

Fair value estimate

  • Fair value range: 2p – 6p per share (implied market cap range £12m – £35m)
  • Methodology: Risk-weighted NAV. Phase 1 feasibility NPV is US$932m post-tax at 8% (revised from US$748m after CC6 EPC estimate), but requires US$312m of new funding. To crudely bracket dilution, funding US$312m at even 15p implies ~1.6bn new shares (versus 587.8m existing), leaving existing holders with ~27% of the enterprise. That implies £185m attributable NPV, or roughly 32p/share on a fully diluted basis — but that is the fully-funded, fully-delivered bull case. Applying probability weights (~50% distressed/near-zero, ~30% funded-with-heavy-dilution ~6p, ~20% bull-case ~25p) yields a mid-point around 4p.
  • Vs latest disclosed market cap of £22.0m: fair value mid (£23.5m) is broadly in line, with roughly ±60% dispersion around it.
  • Absolute upside to mid: ~+7% (fair value 4p vs 3.75p spot).

Sector context

Basic Materials / Basic Resources — confirmed. FAR sits well below typical sector peers on every quality metric: sub-scale (US$4.5m revenue vs producers with billions), pre-production, negative EBITDA, going-concern material uncertainty, and dependent on ~US$500m of external financing (equity plus debt) to reach production. Listed comparables include Largo Inc. (LGO — direct vanadium producer, similar VRFB thesis), Bushveld Minerals (BMN — larger vanadium play, also distressed), and further afield Energy Fuels or Neo Performance Materials for the critical-minerals / rare-earths angle. FAR's grade and cost profile per the feasibility study would place it at the bottom of the global vanadium cost curve — if it gets built.

Investment thesis

  • Genuinely world-class deposit economics if funded. The CC6-updated Phase 1 economics show NPV of US$932m, IRR 31%, and a cash cost of US$0.36/lb V2O5 after by-products — placing it among the lowest-cost vanadium projects globally, before Phase 2 (three times larger) or optional yttrium/REE by-products worth an in-situ estimated US$4.57bn 2026-07-31 strategic update; 2026-04-30 final results.
  • Emerging non-Chinese critical-minerals angle. US government engagement, applications submitted to multiple US departments for grant/debt funding, and downstream partnership discussions with US steel/defence customers give a route to strategic financing rather than pure market equity. Sir Mick Davis on the board and the CEO appointment of Peter Secker (built five greenfield mines, raised US$2bn) meaningfully strengthen credibility with those counterparties 2026-07-31 strategic update.
  • Existing plant now cash-supporting. The 58% capacity uplift from the new roasting process, first CBS sales order (20t agri-tyre), planned ferro-nickel by-product line, US$2m prepayment contracts and US$0.5m Kazakh grant materially reduce near-term working-capital pressure at the existing plant 2026-07-31 strategic update.

Key risks

  • Going concern / bond wall. US$3m due 7 August 2026, US$5m due 11 August 2026, US$5m due 2 October 2026, against US$2.16m cash at 31 March 2026. Company says it "plans to repay" and is "evaluating debt finance offers" for Tranche 2 — but this note is being written days before the first maturity, with no firm refinancing announced. Auditor flagged material uncertainty 2026-04-30 final results.
  • Financing dilution risk is enormous. US$312m of Phase 1 funding must be raised at whatever price the market allows. At today's 3.75p share price, an equity component of any size would be catastrophically dilutive. The company has already issued 75.9m shares in 2025 and 28.6m more in March 2026, mostly at prices well below feasibility bull-case valuation 2026-04-30 final results.
  • Persistent execution slippage. Feasibility study repeatedly delayed (originally H2 2023 → H1 2024 → Q4 2024 → Q2 2025 → mid-October 2025), production shortfalls due to raw-material supply issues in 2022–2024, and no mine construction has yet started. The pattern is one of ambitious timelines that consistently slip multiple filings 2022–2025.

Operating leverage

On its face, FAR would score very high on operating leverage once Phase 1 is built: at feasibility-case pricing (US$8.02/lb V2O5) and cash cost of US$0.36/lb after by-products, operating margin would be ~95%+ on Phase 1 production of 8,500 tonnes V2O5 plus 247,000t CBS at US$500/t. Once fixed capex is sunk, incremental revenue drops almost entirely to cash margin — a textbook capital-intensive commodity producer with structural operating leverage. However, this is entirely theoretical: at today's scale the existing plant generates US$4.5m revenue against US$6.3m cost of sales (negative gross margin), and the ~US$3.6m corporate overhead is fixed regardless. Until Phase 1 is funded and built, operating leverage is a call option, not a live driver. The buyer's "long-tail upside" preference would only be satisfied if construction actually happens.

Value-trap signals

  • Material uncertainty over going concern flagged by auditor in FY25 and FY24 accounts.
  • Bond wall in the next 60 days with no firm refinancing announced.
  • Repeated feasibility study delays over four years.
  • Structural cash-burn: US$8.4m loss in FY25 on US$4.5m revenue; loss-making every year since IPO.
  • Continuous dilutive share issuance at falling prices (including directors accepting shares in lieu of cash) — a hallmark of chronic under-financing.
  • Share price down 44% over 12 months, 17.6% in a single day at the date of the market data snapshot.

Earnings vs. expectations

Management sets forward-looking targets rather than quantitative guidance, so beat/miss analysis is qualitative. On the two most-cited public commitments — publication date of the feasibility study, and delivery of production ramp-up at the existing plant — the record is one of repeated misses: FS timing slipped roughly six times across 2023–2025; production in H1 2024 was "constrained by supplier defaults" versus a plan for full utilisation; nickel by-product commercialisation was announced in H1 2024 but had to be re-scoped when lab results didn't scale. The one clear positive surprise is the CC6 EPC cost estimate (US$261m) coming in lower than the original US$355m in the initial FS, lifting NPV from US$748m to US$932m.

Conviction

Conviction: 2 (low).

  • Anchoring the low conviction: (i) the fair value is dominated by binary outcomes — solvency in Aug/Oct 2026 and Phase 1 financing over the next 12–24 months — neither of which the filings let me handicap with any real precision; (ii) the equity value under a successful-funding scenario depends heavily on the dilution price, which is unknowable; (iii) the delta between bull and bear cases is more than an order of magnitude.
  • What limits it further: the imminent bond maturity means the fair value could be re-rated massively (up or to zero) within weeks of this note, so any point estimate has a very short shelf life.
Filings consulted · 26

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-07-31Strategic Update Including New Ceo Appointment2026-07-31_9697085_strategic-update-including-new-ceo-appointment.md0.95
  2. 2026-04-302025 Final Results2026-04-30_9545283_2025-final-results.md1.00
  3. 2025-10-09Notice OF Agm2025-10-09_9159608_notice-of-agm.md0.26
  4. 2025-09-30Interim Results And Feasibility Study Update2025-09-30_9138762_interim-results-and-feasibility-study-update.md0.77
  5. 2025-04-302024 Final Results2025-04-30_8852854_2024-final-results.md0.65
  6. 2024-09-26Interim Results2024-09-26_8440219_interim-results.md0.58
  7. 2024-09-19Notice OF Agm2024-09-19_8424751_notice-of-agm.md0.20
  8. 2024-04-29Final Results2024-04-29_8160687_final-results.md0.45
  9. 2023-12-22Trading Update2023-12-22_7957967_trading-update.md0.38
  10. 2023-11-01Result OF Agm2023-11-01_7854286_result-of-agm.md0.14
  11. 2023-10-06Notice OF Agm2023-10-06_7800256_notice-of-agm.md0.14
  12. 2023-09-12Investor Presentation2023-09-12_7749141_investor-presentation.md0.32
  13. 2023-09-11Half Year Report2023-09-11_7746472_half-year-report.md0.41
  14. 2023-08-21Trading Update2023-08-21_7706641_trading-update.md0.38
  15. 2023-07-19Investor Presentation Via Investor Meet Company2023-07-19_7640877_investor-presentation-via-investor-meet-company.md0.17
  16. 2023-05-03Investor Presentation Via Investor Meet Company2023-05-03_7509747_investor-presentation-via-investor-meet-company.md0.17
  17. 2023-04-282022 Final Results And Updated Ore Body 1 Mre2023-04-28_7434_2022-final-results-and-updated-ore-body-1-mre.md0.25
  18. 2022-11-10Result OF Agm2022-11-10_7335997_result-of-agm.md0.07
  19. 2022-10-13Notice OF Agm2022-10-13_7303593_notice-of-agm.md0.07
  20. 2022-09-15Result OF Placing And Subscriptions2022-09-15_7365420_result-of-placing-and-subscriptions.md0.17
  21. 2022-09-15Proposed Placing2022-09-15_7316324_proposed-placing.md0.17
  22. 2022-09-15Interim Results2022-09-15_7316261_interim-results.md0.23
  23. 2022-04-29Final Results2022-04-29_7089963_final-results.md0.25
  24. 2021-12-03Result OF Agm2021-12-03_6751950_result-of-agm.md0.07
  25. 2021-11-10Notice OF Agm2021-11-10_6691990_notice-of-agm.md0.07
  26. 2021-09-28Interim Results2021-09-28_6592624_interim-results.md0.23

This research note was authored by a large language model after reading 22 regulatory filings published between 2021-09-28 and 2026-07-31. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.